Gut Associated Metabolites Enhance PD-L1 Blockade Efficacy in Prostate Cancer.

Although Groups B and R did not show statistically significant differences, they showed a trend toward higher PD-L1 levels than Group N ( Fig. 1B ).

also in 53,322 other papers